Home >> Tag Archives: Swift Biosciences—

Tag Archives: Swift Biosciences—

Assay for routine screening of CFTR gene, 7/17

July 2017—Swift Biosciences has commercially released its Accel-Amplicon CFTR Panel, which aims to provide research laboratories with a more comprehensive, next-generation sequencing–based approach to interrogate the coding region and select introns within the cystic fibrosis transmembrane conductance regulator gene for disease-relevant mutations and variants. The panel is designed to offer a higher resolution view into the CFTR gene and produces ready-to-sequence libraries in two hours.

Read More »

Swift to use Horizon NGS reference standards

Nov. 4, 2016—Swift Biosciences will incorporate Horizon Discovery Group‘s human genomic reference standards into its new Accel-Amplicon 56G Oncology Panel for use in research and translational applications. The Accel-Amplicon 56G Oncology Panel is a single tube assay that offers comprehensive and hotspot coverage of 56 clinically relevant oncology-related genes, using a 263-amplicon design to generate multiplex libraries compatible with commonly ...

Read More »

Fluxion, Swift jointly develop NGS workflow, 9/15

Fluxion Biosciences and Swift Biosciences announced a jointly developed workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The workflow uses Fluxion’s IsoFlux System for circulating tumor cell enrichment and Swift’s Accel-Amplicon technology for high-sensitivity variant detection using low starting inputs.

Read More »

PCR-free DNA library kit, 2/14

February 2014—Swift Biosciences announced the launch of the Accel-NGS PCR-free DNA Library Kit for Illumina next-generation sequencing systems. The kit is designed to bring low input requirement, PCR-free capability, and fast, easy workflow to the Illumina platform.

Read More »